Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • VST vs MRNA✓SelectedUSD · MRNAVST vs MRNA performance historyLatest closeAs of-2.14%11/16
Stock and ETF performance explorer

VST vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+283.0%
MRNA return
+179.0%
Excess return
+104.0%
Maximum drawdown
-48.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-2.1%-3.6%+1.5%-2.0%
7D-2.8%-20.0%+17.2%-2.1%
30D-14.4%-1.3%-13.1%-14.4%
3M-12.0%+240.0%-252.0%-17.4%
6M-6.5%+339.0%-345.5%-15.0%
YTD-19.0%+630.0%-648.9%-30.7%
1Y-25.1%+769.1%-794.1%-37.4%
All+283.0%+179.0%+104.0%+280.0%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling